INS and metabolic disease: The modulation of insulin signaling by lipid metabolites such as PA, DAG, and ceramide demonstrates the intricate balance between lipid homeostasis and glucose metabolism, revealing potential metabolic points of intervention for improving insulin sensitivity and combating metabolic disorders.